English  |  正體中文  |  简体中文  |  Items with full text/Total items : 27217/39060
Visitors : 2403136      Online Users : 77
RC Version 4.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Adv. Search

Please use this identifier to cite or link to this item: http://ntour.ntou.edu.tw:8080/ir/handle/987654321/27144

Title: Antiviral applications of RNAi for coronavirus
Authors: Chang-Jer Wu;Yi-Lin Chan
Contributors: NTOU:Department of Food Science
Keywords: antiviral agent;coronavirus;severe acute respiratory syndrome;short interfering RNAs
Date: 2006-02
Issue Date: 2011-10-21T02:23:44Z
Publisher: Expert Opinion on Investigational Drugs
Abstract: Abstract:Until the appearance of severe acute respiratory syndrome (SARS), caused by the SARS coronavirus (SARS-CoV) in early 2003, coronavirus infection was not considered to be serious enough to be controlled by either vaccination or specific antiviral therapy. It is now believed that the availability of antiviral drugs effective against SARS-CoV will be crucial for the control of future SARS outbreaks. Recently, RNA interference has been successfully used as a more specific and efficient method for gene silencing. RNA interference induced by small interfering RNA can inhibit the expression of viral antigens and so provides a new approach to the therapy of pathogenic viruses. This review provides an overview of current information on coronavirus and the application of small interfering RNA in viral therapeutics, with particular reference to SARS-CoV.
Relation: 15(2), pp.89-97
URI: http://ntour.ntou.edu.tw/handle/987654321/27144
Appears in Collections:[食品科學系] 期刊論文

Files in This Item:

There are no files associated with this item.

All items in NTOUR are protected by copyright, with all rights reserved.


著作權政策宣告: 本網站之內容為國立臺灣海洋大學所收錄之機構典藏,無償提供學術研究與公眾教育等公益性使用,請合理使用本網站之內容,以尊重著作權人之權益。
網站維護: 海大圖資處 圖書系統組
DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback